Literature DB >> 16559274

A RAPID METHOD FOR THE MACROSCOPIC AGGLUTINATION TEST.

A Noble1.   

Abstract

Year:  1927        PMID: 16559274      PMCID: PMC374959          DOI: 10.1128/jb.14.5.287-300.1927

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


× No keyword cloud information.
  1 in total

1.  THE KAHN PRECIPITATION TEST FOR SYPHILIS: DEMONSTRATION.

Authors:  R L Kahn
Journal:  Am J Public Health (N Y)       Date:  1924-06
  1 in total
  9 in total

1.  Serological relationships among meningococci.

Authors:  S E BRANHAM
Journal:  Bacteriol Rev       Date:  1953-09

2.  The serological types of haemolytic streptococci in relation to the epidemiology of scarlet fever and its complications.

Authors:  H L de Waal
Journal:  J Hyg (Lond)       Date:  1940-03

3.  The Identification of Neisseria gonorrhoeae by Means of Bacterial Variation and the Detection of Small Colony Forms in Clinical Material.

Authors:  H E Morton; J Shoemaker
Journal:  J Bacteriol       Date:  1945-11       Impact factor: 3.490

4.  A Serological Study of Haemolytic Streptococci.

Authors:  H Plummer
Journal:  J Bacteriol       Date:  1935-07       Impact factor: 3.490

5.  LABORATORY.

Authors:  J F Norton
Journal:  Am J Public Health Nations Health       Date:  1931-05

6.  LABORATORY: RAPID AGGLUTINATION TECHNIC APPLIED TO B. PERTUSSIS AGGLUTINATION.

Authors:  P L Kendrick
Journal:  Am J Public Health Nations Health       Date:  1933-12

7.  Value of Typing Meningococci.

Authors:  S E Branham
Journal:  Am J Public Health Nations Health       Date:  1945-03

8.  Serological studies of Clostridium botulinum type E and related organisms.

Authors:  R K Lynt; H M Solomon; D A Kautter; T Lilly
Journal:  J Bacteriol       Date:  1967-01       Impact factor: 3.490

9.  SPECIFIC CUTANEOUS REACTIONS AND CIRCULATING ANTIBODIES IN THE COURSE OF LOBAR PNEUMONIA : I. CASES RECEIVING NO SERUM THERAPY.

Authors:  M Finland; W D Sutliff
Journal:  J Exp Med       Date:  1931-10-31       Impact factor: 14.307

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.